国产精品A免费一区久久电影_天干天干天啪啪夜爽爽99_chinesevideo国产熟妇_新金瓶悔1一5集免费大片

咨詢熱線

15000266580

當前位置:首頁 >產品中心>細胞庫>人腫瘤細胞、癌細胞>CCL-120.1CCRF HSB-2人急性淋巴母細胞型白血病細胞

CCRF HSB-2人急性淋巴母細胞型白血病細胞

簡要描述:CCRF HSB-2細胞, 人急性淋巴母細胞型白血病細胞 CCRF HSB-2人急性淋巴母細胞型白血病細胞
原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,提供的細胞株背景清楚,
提供參考文獻和*培養條件!

  • 產品型號:CCL-120.1
  • 廠商性質:生產廠家
  • 更新時間:2024-11-21
  • 訪  問  量:2167

產品分類

Product Category

相關文章

Related Articles

詳細介紹

CCRF HSB-2細胞, 人急性淋巴母細胞型白血病細胞

ATCC® Number:CCL-120.1™    Price:$338.00
Designations:CCRF-HSB-2 [CCRF HSB-2, HSB-2]

Depositors:GE Foley

Biosafety Level:1

Shipped:frozen

Medium & Serum:See Propagation

Growth Properties:suspension

Organism:Homo sapiens (human)

Morphology:lymphoblast


Source:Organ: peripheral blood
Disease: acute lymphoblastic leukemia
Cell Type: T lymphoblast;


Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
CCRF HSB-2細胞, 人急性淋巴母細胞型白血病細胞

Tumorigenic:Yes

Antigen Expression:HLA A1, A2, B12, B17, Cw2; CD5 (78%), CD7 (96%)

DNA Profile (STR):Amelogenin: X,Y

CSF1PO: 10,12

D13S317: 10,12

D16S539: 9,13

D5S818: 11,12

D7S820: 11,12

THO1: 9,10

TPOX: 8

vWA: 18,19



Isoenzymes:G6PD, B

Age:11.5 years

Gender:male                         CCRF HSB-2細胞, 人急性淋巴母細胞型白血病細胞

Ethnicity:Caucasian

Comments:Derived from the same buffy coat preparation as CCL-120 (CCRF-SB) by serially transplanting into newborn syrian hamsters.

Propagation:ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C


Subculturing:Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 3 - 5 X 10 exp5 viable cells/ml.

A maximum of 2 - 3 X 10 exp6 viable cells/ml is obtainable.



Preservation:culture medium 95%; DMSO, 5%

Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2005

recommended serum:ATCC 30-2020

derived from same individual:ATCC CCL-120



References:24413: . M.D. Anderson Hospital and Tumor Inst. Monograph. 21: ; 1967.
25969: Adams RA, et al. Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2. Cancer Res. 28: 1121-1125, 1968. PubMed: 4872716
26035: . . Proc. Am. Assoc. Cancer Res. 8: 1, 1967.


















產品咨詢

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
聯系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2024 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網    管理登陸